Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384227 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study
A Early Phase 1 study, sponsored by Anandasabapathy, Sharmila, M.D..
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT01384227 is a Early Phase 1 study that has completed, run by Anandasabapathy, Sharmila, M.D.. The registered enrollment target is 40 participants.
The verdict
NCT01384227, a Early Phase 1 study, has completed, sponsored by Anandasabapathy, Sharmila, M.D..
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of barrett's esophagus in vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is a pilot study of an novel technology, a miniaturized microscope device which can be used during upper endoscopy to image the gastrointestinal epithelium. This is an exploratory, not a comparative, study designed to evaluate the feasibility of using this instrument in Barrett's esophagus.
Interventions
- DRUG Proflavine Hemisulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384227
The ClinicalTrials.gov registry entry for NCT01384227 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anandasabapathy, Sharmila, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proflavine Hemisulfate is the first listed.
NCT01384227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01384227 about?
NCT01384227 is a clinical study titled "Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study". The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of barrett's esophagus in vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is a pilot study of an novel technology, a miniaturized microscope device which can be used during...
What is the current status of trial NCT01384227?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2009-02.
What interventions are being tested in trial NCT01384227?
The interventions under investigation include: Proflavine Hemisulfate (DRUG).
Who is sponsoring clinical trial NCT01384227?
This trial is sponsored by Anandasabapathy, Sharmila, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.